(Q38721413)

5 September 2017

1 reference

title

Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells (English)

1 reference

5 September 2017

Megan D Hoban

1

1 reference

5 September 2017

Zulema Romero

2

1 reference

5 September 2017

Gregory J Cost

3

1 reference

5 September 2017

Matthew Mendel

4

1 reference

5 September 2017

Michael Holmes

5

1 reference

5 September 2017

Donald B Kohn

6

1 reference

5 September 2017

publication date

3 February 2016

1 reference

Current Protocols in Stem Cell Biology

5 September 2017

published in

1 reference

5 September 2017

volume

36

1 reference

5 September 2017

page(s)

5B.4.1-10

1 reference

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Playing the end game: DNA double-strand break repair pathway choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

DNAse treatment following thawing of cryopreserved PBMC is a procedure suitable for lymphocyte functional studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Targeted genome editing in human repopulating haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Human adenoviruses: propagation, purification, quantification, and storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Genome engineering using Adeno-Associated Virus (AAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

Transient gene expression by nonintegrating lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F9780470151808.SC05B04S36

10.1002/9780470151808.SC05B04S36

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference